DR. STEVEN K. REED, PHD
Social Work at 114 Ave, Bellevue, WA
License number
Washington 1071
Category
Social Work
Type
Clinical
Address
Address
1715 114Th Ave SE SUITE 200, Bellevue, WA 98004
Phone
(425) 455-5189
Organization information
See more information about STEVEN K. REED at bizstanding.comEvergreen Behavioral Medicine - Steven K Reed MD
1715 114 Ave SE STE 200, Bellevue, WA 98004
Categories:
Psychiatry Physicians, Psychologists
Phone:
(425) 455-5189 (Phone)
Professional information
Compounds And Methods For Diagnosis Of Lung Cancer
US Patent:
6210883, Apr 3, 2001
Filed:
Mar 18, 1998
Appl. No.:
9/040984
Inventors:
Steven G. Reed - Bellevue WA
Tong Tong Wang - Medina WA
Tong Tong Wang - Medina WA
Assignee:
Corixa Corporation - Seattle WA
International Classification:
C12Q 168, C07H 2102, C07H 2104, C12P 1934
US Classification:
435 6
Abstract:
Compounds and methods for treating lung cancer are provided. The inventive compounds include polypeptides containing at least a portion of a lung tumor protein. Vaccines and pharmaceutical compositions for immunotherapy of lung cancer comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided, together with DNA molecules for preparing the inventive polypeptides.
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer
US Patent:
2011015, Jun 23, 2011
Filed:
Oct 30, 2007
Appl. No.:
11/929831
Inventors:
Steven G. Reed - Bellevue WA, US
Jiangchun Xu - Bellevue WA, US
Davin C. Dillon - Issaquah WA, US
Marc W. Retter - Carnation WA, US
Susan L. Harlocker - Seattle WA, US
Jiangchun Xu - Bellevue WA, US
Davin C. Dillon - Issaquah WA, US
Marc W. Retter - Carnation WA, US
Susan L. Harlocker - Seattle WA, US
Assignee:
CORIXA CORPORATION - Hamilton MT
International Classification:
A61K 39/00, C07K 2/00, C07H 21/04, A61P 35/00, G01N 33/68, C12N 5/0783, A61K 35/12, A61P 37/04
US Classification:
4241921, 530300, 536 231, 436 64, 435375, 435325, 424 9371, 4241841
Abstract:
Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer.
Steven Kenneth Reed, Bellevue WA
Specialties:
Psychologist
Address:
1715 114Th Ave Se, Bellevue, WA 98004
Vaccine Composition Containing Synthetic Adjuvant
US Patent:
2013008, Apr 4, 2013
Filed:
Aug 30, 2012
Appl. No.:
13/599701
Inventors:
STEVEN G. REED - Bellevue WA, US
Darrick Carter - Seattle WA, US
Darrick Carter - Seattle WA, US
Assignee:
Infectious Disease Research Institute - Seattle WA
International Classification:
A61K 39/39, A61K 45/06
US Classification:
4242101, 4242091
Abstract:
Compositions and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed based on the discovery of useful immunological adjuvant properties in a synthetic, glucopyranosyl lipid adjuvant (GLA) that is provided in substantially homogeneous form. Chemically defined, synthetic GLA offers a consistent vaccine component from lot to lot without the fluctuations in contaminants or activity that compromise natural-product adjuvants. Also provided are vaccines and pharmaceutical compositions that include GLA and one or more of an antigen, a Toll-like receptor (TLR) agonist, a co-adjuvant and a carrier such as a pharmaceutical carrier.
Compounds And Methods For Diagnosis And Treatment Of Leishmaniasis
US Patent:
2011028, Nov 17, 2011
Filed:
Oct 11, 2010
Appl. No.:
12/901961
Inventors:
Yasuyuki Goto - Seattle WA, US
Steven G. Reed - Bellevue WA, US
Steven G. Reed - Bellevue WA, US
Assignee:
INFECTIOUS DISEASE RESEARCH INSTITUTE - Seattle WA
International Classification:
A61K 38/17, A61P 37/02, A61P 33/02, A61K 38/10, C07K 14/435, C40B 60/12
US Classification:
4241921, 530350, 506 39, 514 214
Abstract:
Compounds and methods are provided for diagnosing, preventing, treating and detecting leishmaniasis infection and stimulating immune responses in patients are disclosed. The compounds disclosed are include polypeptides and fusion proteins that contain at least one immunogenic portion of one or more antigens, or a variant thereof. Additionally, methods of screening a screening library for tandem repeat proteins that have immunogenic properties are disclosed. Vaccines and pharmaceutical compositions comprising polynucleotides, polypeptides, fusion proteins and variants thereof that may be used for the prevention and therapy of leishmaniasis, as well as for the detection of Leishmaniasis infection are described.
Compounds And Methods For Immunotherapy And Diagnosis Of Tuberculosis
US Patent:
2012017, Jul 5, 2012
Filed:
Oct 29, 2007
Appl. No.:
11/927558
Inventors:
Steven G. Reed - Bellevue WA, US
Yasir A.W. Skeiky - Seattle WA, US
Davin C. Dillon - Redmond WA, US
Antonio Campos-Neto - Bainbridge Island WA, US
Raymond Houghton - Bothell WA, US
Thomas S. Vedvick - Federal Way WA, US
Daniel R. Twardzik - Bainbridge Island WA, US
Michael J. Lodes - Seattle WA, US
Ronald C. Hendrickson - Seattle WA, US
Yasir A.W. Skeiky - Seattle WA, US
Davin C. Dillon - Redmond WA, US
Antonio Campos-Neto - Bainbridge Island WA, US
Raymond Houghton - Bothell WA, US
Thomas S. Vedvick - Federal Way WA, US
Daniel R. Twardzik - Bainbridge Island WA, US
Michael J. Lodes - Seattle WA, US
Ronald C. Hendrickson - Seattle WA, US
Assignee:
CORIXA CORPORATION - Seattle WA
International Classification:
A61K 47/00, C12N 1/21, A61P 31/06, A61K 31/7088, C07H 21/04, C12P 21/04, C12N 15/63
US Classification:
4242781, 435 691, 435 697, 43525231, 4353201, 514 44 R, 536 231, 536 234
Abstract:
Compounds and methods for inducing protective immunity against tuberculosis are disclosed. The compounds provided include polypeptides that contain at least one immunogenic portion of one or more proteins and DNA molecules encoding such polypeptides. Such compounds may be formulated into vaccines and/or pharmaceutical compositions for immunization against infection, or may be used for the diagnosis of tuberculosis.
Compositions And Methods For The Detection Of Trypanosoma Cruzi Infection
US Patent:
2008010, May 8, 2008
Filed:
May 2, 2007
Appl. No.:
11/743534
Inventors:
Steven Reed - Bellevue WA, US
Assignee:
INFECTIOUS DISEASE RESEARCH INSTITUTE - Seattle WA
International Classification:
A61K 39/005, A61P 33/02, C12N 1/21, C12N 15/12, C12N 15/63, C12N 5/10, G01N 33/53
US Classification:
4242691, 4352523, 43525233, 4353201, 435325, 435348, 435358, 435 72, 530350, 536 237
Abstract:
The invention provides antigenic polypeptides, polynucleotides, and fusions thereof, as well as compositions comprising same. Also provided are diagnostic kits and methods for the diagnosis of infection and in screening blood supplies.
Leishmania Sterol 24-C-Methyltransferase Compositions For The Prevention, Treatment And Diagnosis Of Leishmaniasis
US Patent:
2009004, Feb 12, 2009
Filed:
Jul 11, 2008
Appl. No.:
12/171729
Inventors:
Steven Reed - Bellevue WA, US
Yasuyuki Goto - Seattle WA, US
Yasuyuki Goto - Seattle WA, US
Assignee:
INFECTIOUS DISEASE RESEARCH INSTITUTE - Seattle WA
International Classification:
A61K 39/00, A61K 39/008, A61P 37/04
US Classification:
4241921, 4242691, 4241841
Abstract:
Compositions and methods for preventing, treating and detecting leishmaniasis are disclosed. The compositions generally comprise sterol 24-c-methyltransferase (SMT) polypeptides, portions, variants and/or fusions, as well as polynucleotides encoding SMT polypeptides, portions, variants and/or fusions.
Method Of Detecting Anti-Leishmania Parasite Antibodies
US Patent:
5411865, May 2, 1995
Filed:
Jan 15, 1993
Appl. No.:
8/006676
Inventors:
Steven Reed - Bellevue WA
Assignee:
Iasys Corporation - Seattle WA
International Classification:
G01N 33569
US Classification:
435 722
Abstract:
A method for detecting anti-Leishmania parasite antibodies to a 230 kDa antigen present in Leishmania chagasi and Leishmania donovani is disclosed which comprises obtaining a sample from an individual, contacting the sample with a recombinant K39 repeat unit antigen comprising the amino acid sequence as shown in SEQ ID NO:3, and detecting the presence of anti-Leishmania parasite antibodies in the sample which bind to the recombinant K39 repeat unit antigen.
Methods For Enhancement Of Protective Immune Responses
US Patent:
5876735, Mar 2, 1999
Filed:
Feb 23, 1996
Appl. No.:
8/607509
Inventors:
Steven G. Reed - Bellevue WA
Assignee:
Corixa Corporation - Seattle WA
International Classification:
A61K 3900, A61K 39002, A61K 39008, A61K 9127
US Classification:
4242691
Abstract:
Methods for eliciting or enhancing immune responses to antigens, including tumor antigens, are provided. The methods employ polypeptides or nucleic acid compositions that contain at least a biologically active portion of a Leishmania braziliensis or Leishmania major homologue of the eukaryotic initiation factor 4A, or a variant thereof. Such polypeptides and compositions are useful for enhancing or eliciting a patient's cellular and/or humoral immune response, for instance within methods for treating tumors.